Dr. Jan Tesarik obtained his MD degree in 1979
and PhD in 1982. He realized the world´s first successful Gamete
Intra-Fallopian Transfer (GIFT), in 1982, and the first childbirths after
oocyte fertilization with round spermatids
(ROSI) and with in-vitro cultured elongating spermatids (ELSI) in 1995
and 1998, respectively. He developed an original technique for nuclear transfer
in mature human oocytes (2000), currently popular as the “3-parent-baby
technique”. He described beneficial
effects of growth hormone (GH) on oocyte quality in women of >40 years old,
and younger women suffering from polycystic ovary syndrome. He also showed a
beneficial effect of GH on uterine receptivity in women with recurrent
implantation failure. He developed several original virtual imaging endoscopy
techniques, based on ultrasound scan, including virtual hysteroscopy, virtual
salpingoscopy, virtual embryoscopy and virtual folliculoscopy. Since the outbreak of the coronavirus disease-19
(COVID-19) pandemic, he was investigating into different anti-COVID agents,
with particular reference to the preservation of fertility and protection of
pregnant women. He is author of >400 scientific publications
(articles and book chapters) and editor of 2 books. He worked at the Purkyne
University (Brno, Czechoslovakia) and later at the American Hospital of Paris
(France). At present he is Director of MARGen (Molecular Asssisted Reproduction
and Genetics) Clinic in Granada (Spain).
Dr. Jan Tesarik obtained his MD degree in 1979
and PhD in 1982. He realized the world´s first successful Gamete
Intra-Fallopian Transfer (GIFT), in 1982, and the first childbirths after
oocyte fertilization with round spermatids
(ROSI) and with in-vitro cultured elongating spermatids (ELSI) in 1995
and 1998, respectively. He developed an original technique for nuclear transfer
in mature human oocytes (2000), currently popular as the “3-parent-baby
technique”. He described beneficial
effects of growth hormone (GH) on oocyte quality in women of >40 years old,
and younger women suffering from polycystic ovary syndrome. He also showed a
beneficial effect of GH on uterine receptivity in women with recurrent
implantation failure. He developed several original virtual imaging endoscopy
techniques, based on ultrasound scan, including virtual hysteroscopy, virtual
salpingoscopy, virtual embryoscopy and virtual folliculoscopy. Since the outbreak of the coronavirus disease-19
(COVID-19) pandemic, he was investigating into different anti-COVID agents,
with particular reference to the preservation of fertility and protection of
pregnant women. He is author of >400 scientific publications
(articles and book chapters) and editor of 2 books. He worked at the Purkyne
University (Brno, Czechoslovakia) and later at the American Hospital of Paris
(France). At present he is Director of MARGen (Molecular Asssisted Reproduction
and Genetics) Clinic in Granada (Spain).